Co-Authors
This is a "connection" page, showing publications co-authored by MASATAKA SUZUKI and Greyson Biegert.
Connection Strength
2.400
-
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma. Mol Ther Oncol. 2025 Jun 18; 33(2):201006.
Score: 0.972
-
Current development in adenoviral vectors for cancer immunotherapy. Mol Ther Oncolytics. 2021 Dec 17; 23:571-581.
Score: 0.762
-
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. J Immunother Cancer. 2024 Dec 09; 12(12).
Score: 0.235
-
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer. Mol Ther Oncol. 2024 Dec 19; 32(4):200899.
Score: 0.233
-
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy. Cancers (Basel). 2022 Jun 02; 14(11).
Score: 0.198